Skip to main content
EN
  1. Learn the basics
  2. Find stocks
  3. Understand a stock

ACTUATE THERAPEUTICS, INC.

ACTU United States NASDAQ
Last Close: Market Cap: Currency: USD Reports in: Sector: Health Care Industry:

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapeutics targeting glycogen synthase kinase-3 beta (GSK-3β). The company’s lead product candidate, elraglusib (9-ING-41), is an intravenous GSK-3β inhibitor currently under evaluation in clinical trials for the treatment of various cancers, including pancreatic, lung, and other solid tumors, as well as certain hematologic malignancies. Actuate operates in a single business segment focused on the research, development, and clinical advancement of its GSK-3β inhibitor platform. The company’s development activities are directed toward oncology indications with significant unmet medical need. Its product candidates are designed for use in combination with existing chemotherapy regimens or other targeted agents in adult and pediatric patient populations.

In short

Loading the key numbers…

What the sector means for this company

These sentences describe the numbers; they are not a recommendation. This content is not investment advice.

Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.

Price chart

Daily candles · prices in USD

View
Layers
From
To

Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.

Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.

Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.

News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company and how factual it is. What the ratings mean.